Patient Decision Aid (PDA) for Patients with Rheumatoid Arthritis Reduces Decisional Confict and Improves Readiness for Treatment Decision Making
Ver/ Abrir
Impacto
Scholar |
Otros documentos de la autoría: Pablos, José Luis; Jover, Juan Ángel; Román-Ivorra, José Andrés; Inciarte-Mundo, Jose; Dilla, Tatiana; Sacristán, José Antonio; Comellas, Marta; Lizán, Luis
Metadatos
Mostrar el registro completo del ítemcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONMetadatos
Título
Patient Decision Aid (PDA) for Patients with Rheumatoid Arthritis Reduces Decisional Confict and Improves Readiness for Treatment Decision MakingAutoría
Fecha de publicación
2020Editor
SpringerISSN
1178-1653; 1178-1661Cita bibliográfica
Pablos, J.L., Jover, J.A., Roman-Ivorra, J.A. et al. Patient Decision Aid (PDA) for Patients with Rheumatoid Arthritis Reduces Decisional Conflict and Improves Readiness for Treatment Decision Making. Patient 13, 57–69 (2020). https://doi.org/10.1007/s40271-019-00381-yTipo de documento
info:eu-repo/semantics/articleVersión de la editorial
https://link.springer.com/article/10.1007%2Fs40271-019-00381-yVersión
info:eu-repo/semantics/publishedVersionResumen
Objectives The aim of this study was to develop and assess the efectiveness of a patient decision aid (PDA) to support
treatment decision making in Spanish patients with moderate-to-severe rheumatoid arthritis (RA) ... [+]
Objectives The aim of this study was to develop and assess the efectiveness of a patient decision aid (PDA) to support
treatment decision making in Spanish patients with moderate-to-severe rheumatoid arthritis (RA) who fail to achieve the
therapeutic goal with the current disease-modifying antirheumatic treatment strategy.
Methods The PDA was developed in accordance with the International Patient Decision Aids Standards recommendations. A
steering group led the project. Three literature reviews and two focus groups were performed to develop the PDA prototype.
To check its comprehensibility, acceptability, and feasibility, alpha-testing was performed using the Decision Support Acceptability Scale (DSAS). Beta-testing was conducted to assess preliminary evidence of PDA efcacy using the Decisional Confict
Scale (DCS) before and after PDA use. Readiness was evaluated using the Preparation for Decision Making Scale (PDMS).
Results The PDA included (1) a brief description of RA, (2) treatment information, and (3) a values clarifcation section. Alphatesting revealed that most patients considered that the information was presented in a good or excellent way and it could help
clarify their values and facilitate treatment decision making. Most rheumatologists agreed that the PDA was easy to understand,
to use, and allowed them to reach a shared decision. Beta-testing showed that PDA signifcantly reduced overall patients’ decisional confict [33.2 (DE: 21.4) vs 24.6 (23.5); p<0.001] and prepared the patient for decision making [PDMS: 67.5 (21.0)].
Conclusions We developed a PDA for Spanish patients with moderate-to-severe RA that reduces patients’ decisional confict
and increases their readiness for decision making. The use of this PDA in routine clinical practice may improve the quality
of the decision-making process and the quality of the choices made. [-]
Publicado en
The Patient - Patient-Centered Outcomes Research (2020) 13.Derechos de acceso
info:eu-repo/semantics/openAccess
Aparece en las colecciones
- MED_Articles [642]
El ítem tiene asociados los siguientes ficheros de licencia:
Excepto si se señala otra cosa, la licencia del ítem se describe como: © The Author(s) 2019.
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License
(http://creativecommons.org/licenses/by-nc/4.0/), which permits any
noncommercial use, distribution, and reproduction in any medium,
provided you give appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons license, and indicate
if changes were made.